Komo Announces Product of the Year Nomination by the B.C. Food and Beverage Association Life Science Investing
Bristol Myers Squibb Announces Adjuvant Treatment with Opdivo Demonstrated Statistically Significant and Clinically Meaningful Improvement in Recurrence-Free Survival in Patients with Stage IIB/C Melanoma in the CheckMate -76K Trial Pharmaceutical Investing
AbbVie to Present Data from Growing Neuroscience and Movement Disorders Portfolio at 2022 MDS International Congress Pharmaceutical Investing
AbbVie Announces Public Voting Open for 30th Annual Cystic Fibrosis Scholarship "Thriving Student Awards" Pharmaceutical Investing
BriaCell Partners with Caris Life Sciences® to Expand Patient Outreach and Molecular Profiling Pharmaceutical Investing
Mindset Pharma Receives Scientific Advice from UK Regulator Facilitating Advancement of Phase 1 First-In-Human Clinical Trial Plan for Its Lead Clinical Candidate, MSP-1014 Life Science Investing
Gilead Foundation Awards $20 Million to Organizations Working to Advance Health Through Education Equity Pharmaceutical Investing
Allergan Aesthetics and BOTOX® Cosmetic Reveal New 'See Yourself' Campaign Cast, Spotlighting 25 Real People and Their Stories Pharmaceutical Investing
The Gummy Project Announces Expansion into Sobeys Retail Network in British Columbia Life Science Investing
